文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

姑息治疗时机、临终质量指标与医疗资源利用

Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论卵巢癌患者死亡前3个月以上启动姑息治疗,与临终激进治疗(OR 0.47)、院内死亡(OR 0.54)、ICU入住(OR 0.46)风险较低相关。

该研究基于加拿大安大略省2006至2018年关联行政健康数据,纳入8297例卵巢癌死亡患者,采用基于人群的回顾性队列设计,评估姑息治疗启动时机与临终质量指标的关系。结果显示,32.1%的患者在生命最后3个月才接受姑息治疗;死亡前3个月以上启动任何姑息治疗与较低的激进临终治疗(OR 0.47,95%CI 0.37-0.60)、院内死亡(OR 0.54,95%CI 0.45-0.65)和ICU入住(OR 0.46,95%CI 0.27-0.76)相关;死亡前3至6个月接受专科姑息会诊与晚期化疗可能性降低相关(OR 0.46,95%CI 0.24-0.88)。作者认为早期姑息治疗可能减少激进临终治疗,并呼吁实施早期启动策略以优化临终照护质量和医疗资源利用。

要点

  • 8297例卵巢癌死亡患者中,32.1%(2667例)在生命最后3个月才接受姑息治疗,属晚期启动。
  • 死亡前3个月以上启动任何姑息治疗与较低激进临终治疗相关(OR 0.47,95%CI 0.37-0.60)。
  • 早期姑息治疗与较低院内死亡(OR 0.54,95%CI 0.45-0.65)和ICU入住(OR 0.46,95%CI 0.27-0.76)相关。
  • 死亡前3至6个月接受专科姑息会诊与晚期化疗可能性降低相关(OR 0.46,95%CI 0.24-0.88)。
  • 作者建议实施早期姑息治疗启动策略,以优化临终照护质量和医疗资源利用。

适用人群与场景

  • 加拿大安大略省2006至2018年死亡的卵巢癌患者,基于关联行政健康数据识别。
  • 纳入所有医疗部门和医疗专业人员(专科和非专科)提供的姑息治疗;排除标准原文未报告。

诊断标准与关键阈值

  • 晚期姑息治疗定义为死亡前3个月或更短时间内启动。
  • 临终质量指标包括:急诊就诊、生命最后30天内住院或ICU入住、生命最后14天内化疗、院内死亡及激进治疗的复合指标。

研究设计与关键结果

  • 研究类型:基于人群的回顾性队列研究,纳入8297例卵巢癌死亡患者;死亡时平均(SD)年龄69.6(13.1)岁,平均(SD)肿瘤生存期2.8(3.9)年。
  • 在3958例已知癌症分期的患者中,3495例(88.3%)为III期或IV期。
  • 2667例(32.1%)在生命最后3个月接受晚期姑息治疗。
  • 多因素回归分析:死亡前3个月以上启动任何姑息治疗与较低激进临终治疗相关(OR 0.47,95%CI 0.37-0.60)、较低院内死亡(OR 0.54,95%CI 0.45-0.65)、较低ICU入住(OR 0.46,95%CI 0.27-0.76)。
  • 死亡前3至6个月接受专科姑息会诊与晚期化疗可能性降低相关(OR 0.46,95%CI 0.24-0.88)。

证据类型、等级与局限

  • 证据类型:基于人群的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期姑息治疗可能比晚期姑息治疗减少激进临终治疗。
  • 作者建议,需要实施早期姑息治疗启动策略,以优化临终照护质量和医疗资源利用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Despite research supporting the benefits of early palliative care, timely initiation by gynecologic oncology patients is reportedly low, which may limit the effectiveness of palliative care.

OBJECTIVE: To investigate the association of the timing of palliative care initiation with the aggressiveness of end-of-life care using established quality indicators among patients with ovarian cancer.

DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study of ovarian cancer decedents used linked administrative health care data to identify palliative care provision across all health care sectors and health care professionals (specialist and nonspecialist) and end-of-life quality indicators in Ontario, Canada, from 2006 to 2018. Data analyses were performed July 12, 2024.

MAIN OUTCOMES AND MEASURES: The primary outcome was the associations between the timing of palliative care and end-of-life quality indicators, including emergency department use, hospital or intensive care unit admission in the last 30 days of life, chemotherapy in last 14 days of life, death in the hospital, and a composite measure of aggressive care. Late palliative care was defined as 3 months or less prior to death.

RESULTS: There were 8297 ovarian cancer decedents. Their mean (SD) age at death was 69.6 (13.1) years, and their mean (SD) oncologic survival was 2.8 (3.9) years. Among 3958 patients with known cancer stage, 3495 (88.3%) presented with stage III or IV disease. One-third of patients (2667 [32.1%]) received late palliative care in the final 3 months of life. Results of multivariable regression analysis indicated that any palliative care initiated earlier than 3 months before death was associated with lower rates of aggressive end-of-life care (odds ratio [OR], 0.47 [95% CI, 0.37-0.60]), death in hospital (OR, 0.54 [95% CI, 0.45-0.65]), and intensive care unit admission (OR, 0.46 [95% CI, 0.27-0.76]). Specialist palliative consultation from 3 months up to 6 monts before death was associated with decreased likelihood of late chemotherapy (OR, 0.46 [95% CI, 0.24-0.88]).

CONCLUSIONS: Findings from this cohort study suggested that early palliative care may be associated with less-aggressive end-of-life care than late palliative care. Implementation strategies for early palliative care initiation are needed to optimize care quality and health resource utilization at the end of life.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Mah SJ, Carter Ramirez DM, Schnarr K, et al. Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization. JAMA Netw Open. 2024. PMID: 39466244. doi:10.1001/jamanetworkopen.2024.40977

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。